ITOC (iTonic Holdings) ROCE %: -92.90% (As of Dec. 2025)


ITOC iTonic Holdings Ltd ITOC
14 GF Score
Price $0.31
! 6 Warning Signs
View Full Analysis

What is iTonic Holdings ROCE %?

iTonic Holdings ITOC -1.29% 14 ROCE % is -92.90% as of Dec. 2025. GuruFocus rates ITOC with a GF Score™ of 14/100. The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. iTonic Holdings's annualized ROCE % for the quarter that ended in Dec. 2025 was -92.90%.

iTonic Holdings  (NAS:ITOC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

iTonic Holdings ROCE % Related Terms

iTonic Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for iTonic Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iTonic Holdings ROCE % Chart

iTonic Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
17.41 7.82 -45.68 -20.07 -69.72

iTonic Holdings Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only -71.08 -237.77 -23.14 -75.52 -92.90
ITOC
14GF Score
iTonic Holdings Ltd ITOC
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iTonic Holdings ROCE % Calculation

iTonic Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-5.165/( ( (6.723 - 0.539) + (9.096 - 0.463) )/ 2 )
=-5.165/( (6.184+8.633)/ 2 )
=-5.165/7.4085
=-69.72 %

iTonic Holdings's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-6.208/( ( (5.115 - 0.383) + (9.096 - 0.463) )/ 2 )
=-6.208/( ( 4.732 + 8.633 )/ 2 )
=-6.208/6.6825
=-92.90 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -92.90% mean?
iTonic Holdings (ITOC) has a ROCE % of -92.90% as of Dec. 2025.
Is iTonic Holdings' ROCE % too high?
iTonic Holdings' current ROCE % is -92.90%. Overall, iTonic Holdings has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does iTonic Holdings' ROCE % compare to HSCS and FEED?
iTonic Holdings' ROCE % of -92.90% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iTonic Holdings's current ROCE % is -92.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iTonic Holdings stock overvalued right now?
iTonic Holdings (ITOC) has a current ROCE % of -92.90%. The current ROCE % is -92.90%. iTonic Holdings' overall GF Score™ is 14/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For iTonic Holdings (ITOC), the current ROCE % is -92.90% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

iTonic Holdings Business Description

Address No. 8 Beiyuan Xiaojie, Room 405, LongHu Hailanyinqing Industrial Park, Building 6, Chaoyang District, Beijing, CHN
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.
14GF Score

Get the complete analysis for ITOC

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.31
Price